Dr. Ci:Labo VC100 Essence Lotion EX vitamin C toner in a 150 ml clear bottle
Promising for Dullness
What Makes This Different

The combination of two advanced vitamin C derivatives (APPS and ethyl ascorbic acid), quad hyaluronic acid complex, and niacinamide brightening support in a single toner is unusually sophisticated. APPS in particular is among the most-researched advanced vitamin C derivatives in cosmetic chemistry. Dr. Ci:Labo's dermatologist-developed brand positioning adds clinical credibility beyond typical Japanese skincare brands.

Dr. Ci:Labo

Dr. Ci:Labo VC100 Essence Lotion EX Review

Dermatologist Vitamin C Toner
toner liquid clinical Fungal Acne Safe Not Cruelty Free

Dr. Ci:Labo's premium vitamin C toner combines two advanced vitamin C derivatives (APPS and ethyl ascorbic acid) with a quad hyaluronic acid hydration complex and niacinamide brightening support. The dermatologist-developed positioning and formulation sophistication justify the premium pricing for users specifically seeking Japanese cosmeceutical vitamin C toner depth.

$75.00
150 ml
4.5 ★★★★★
12,000 reviews
Made in Japan Launched 2018 All-year use PAO: 6 months
Buy at Amazon ♥
Run it through our tools Clashes with my routine? Pregnancy-safe? Find a cheaper dupe Patch-test it first
Verdicts

How well it fits each concern

Verdict by concern tap a concern for the case

Promisingfor DullnessHyaluronic Acid has trial-level evidence for dullness but no guideline or regulatory standing yet — promising, short of a recommendation; the other actives here are not yet assessed for it.Moderate evidenceStandard tolerabilityNo reviews collected yet

The case for it

  1. Quad Hyaluronic Acid Complex has trial-level evidence for this concern but no guideline or regulatory standing yet.
  2. It is plausibly present at a working level, though the concentration is not declared.
  3. The formula carries no trigger this concern is sensitive to, with the cautions noted.

What would change this: A declared concentration would move this to a firmer reading of the dose.

Same rule for everyone. “Promising” is the verdict on 7,858 of 45,024 concern verdicts across the catalog; rule R9p decided 7,858 of them. Unchanged since September 5, 2026, engine 5.1.1.

Brand or formulator? Disclose a concentration or correct a fact →

Show the work
Rule
R9p — 0.5.0: 'Unproven' beside three filled dots read as one question answered twice with opposite words (7,018 rows). The chip measures standing, the dots measure trial volume; where the row carries at least one RCT or a tier-2 source (moderate dots) and the active is present at a working level, the honest word is Promising. Unproven is reserved for plausible-standing rows with limited or weak evidence, or an under-dosed form. Same rank as Unproven — a bet either way; the dots order them. · the full register
Carrying active
Quad Hyaluronic Acid Complex
Standing
plausible — trials support it
Form
plausible
Tolerability
standard
Row checked
against its sources on July 17, 2026 (evidence table ev-2026.09-r228)

The studies behind the evidence row

All dullness products →
Good choicefor HyperpigmentationNiacinamide is a trial-supported active for hyperpigmentation; this liquid carries it, though the concentration is not declared.Moderate evidenceStandard tolerabilityNo reviews collected yet

The case for it

  1. Niacinamide has trial-supported standing for this concern.
  2. It is plausibly present at a working level, though the concentration is not declared.
  3. The formula carries no trigger this concern is sensitive to, with the cautions noted.

What would change this: A declared concentration would move this to a firmer reading of the dose.

Same rule for everyone. “Good choice” is the verdict on 9,564 of 45,024 concern verdicts across the catalog; rule R5 decided 9,072 of them. Unchanged since September 5, 2026, engine 5.1.1.

Brand or formulator? Disclose a concentration or correct a fact →

Show the work
Rule
R5 — Trial-supported or guideline-supported active, adequately or plausibly dosed. · the full register
Carrying active
Niacinamide
Standing
supported — trials support it
Form
plausible — studied range 2–5%, from the trials on the row; needs leave-on contact; judge it after ~8 weeks
Tolerability
standard
Row checked
against its sources on July 17, 2026 (evidence table ev-2026.09-r228)

The studies behind the evidence row

All hyperpigmentation products →
Promisingfor Dark SpotsVitamin C has trial-level evidence for dark spots but no guideline or regulatory standing yet — promising, short of a recommendation; the other actives here are not yet assessed for it.Moderate evidenceStandard tolerabilityNo reviews collected yet

The case for it

  1. APPS has trial-level evidence for this concern but no guideline or regulatory standing yet.
  2. It is plausibly present at a working level, though the concentration is not declared.
  3. The formula carries no trigger this concern is sensitive to, with the cautions noted.

What would change this: A declared concentration would move this to a firmer reading of the dose.

Same rule for everyone. “Promising” is the verdict on 7,858 of 45,024 concern verdicts across the catalog; rule R9p decided 7,858 of them. Unchanged since September 5, 2026, engine 5.1.1.

Brand or formulator? Disclose a concentration or correct a fact →

Show the work
Rule
R9p — 0.5.0: 'Unproven' beside three filled dots read as one question answered twice with opposite words (7,018 rows). The chip measures standing, the dots measure trial volume; where the row carries at least one RCT or a tier-2 source (moderate dots) and the active is present at a working level, the honest word is Promising. Unproven is reserved for plausible-standing rows with limited or weak evidence, or an under-dosed form. Same rank as Unproven — a bet either way; the dots order them. · the full register
Carrying active
APPS
Standing
plausible — trials support it
Form
plausible — studied range 1–28%, from the trials on the row; needs leave-on contact; judge it after ~12 weeks
Tolerability
standard
Row checked
against its sources on July 17, 2026 (evidence table ev-2026.09-r228)

The studies behind the evidence row

All dark spots products →
Promisingfor AgingVitamin C has trial-level evidence for aging but no guideline or regulatory standing yet — promising, short of a recommendation; the other actives here are not yet assessed for it.Moderate evidenceStandard tolerabilityNo reviews collected yet

The case for it

  1. APPS has trial-level evidence for this concern but no guideline or regulatory standing yet.
  2. It is plausibly present at a working level, though the concentration is not declared.
  3. The formula carries no trigger this concern is sensitive to, with the cautions noted.

What would change this: A declared concentration would move this to a firmer reading of the dose.

Same rule for everyone. “Promising” is the verdict on 7,858 of 45,024 concern verdicts across the catalog; rule R9p decided 7,858 of them. Unchanged since September 5, 2026, engine 5.1.1.

Brand or formulator? Disclose a concentration or correct a fact →

Show the work
Rule
R9p — 0.5.0: 'Unproven' beside three filled dots read as one question answered twice with opposite words (7,018 rows). The chip measures standing, the dots measure trial volume; where the row carries at least one RCT or a tier-2 source (moderate dots) and the active is present at a working level, the honest word is Promising. Unproven is reserved for plausible-standing rows with limited or weak evidence, or an under-dosed form. Same rank as Unproven — a bet either way; the dots order them. · the full register
Carrying active
APPS
Standing
plausible — trials support it
Form
plausible — studied range 5%, from the trials on the row; needs leave-on contact; judge it after ~12 weeks
Tolerability
standard
Row checked
against its sources on July 17, 2026 (evidence table ev-2026.09-r228)

The studies behind the evidence row

All aging products →
Promisingfor Sun DamageVitamin C has trial-level evidence for sun damage but no guideline or regulatory standing yet — promising, short of a recommendation; the other actives here are not yet assessed for it.Moderate evidenceStandard tolerabilityNo reviews collected yet

The case for it

  1. APPS has trial-level evidence for this concern but no guideline or regulatory standing yet.
  2. It is plausibly present at a working level, though the concentration is not declared.
  3. The formula carries no trigger this concern is sensitive to, with the cautions noted.

What would change this: A declared concentration would move this to a firmer reading of the dose.

Same rule for everyone. “Promising” is the verdict on 7,858 of 45,024 concern verdicts across the catalog; rule R9p decided 7,858 of them. Unchanged since September 5, 2026, engine 5.1.1.

Brand or formulator? Disclose a concentration or correct a fact →

Show the work
Rule
R9p — 0.5.0: 'Unproven' beside three filled dots read as one question answered twice with opposite words (7,018 rows). The chip measures standing, the dots measure trial volume; where the row carries at least one RCT or a tier-2 source (moderate dots) and the active is present at a working level, the honest word is Promising. Unproven is reserved for plausible-standing rows with limited or weak evidence, or an under-dosed form. Same rank as Unproven — a bet either way; the dots order them. · the full register
Carrying active
APPS
Standing
plausible — trials support it
Form
plausible
Tolerability
standard
Row checked
against its sources on July 17, 2026 (evidence table ev-2026.09-r228)

The studies behind the evidence row

All sun damage products →

Does the jobDoes what a toner is for: not alcohol-driven, adds something real. Not measured from the label: restores skin pH, plays well with what follows.

A verdict is DermApproved’s assessment of how well a product’s ingredients fit a concern — never a claim about what the product treats. Evidence dots and collected reviews sit beside it and are never blended in. Rules 0.5.1 · evidence table ev-2026.09-r228 · how we decide

Assessment

Pros & Cons

Pros

  • ✓ Dual vitamin C derivatives (APPS + ethyl ascorbic acid) more sophisticated than single-form competitors
  • ✓ Quad hyaluronic acid complex delivers substantial layered hydration
  • ✓ Niacinamide adds complementary brightening and barrier-supporting action
  • ✓ Dermatologist-developed brand credibility
  • ✓ Suitable for daily use across most skin types
  • ✓ Pairs synergistically with the broader VC100 line

Cons

  • ✗ Premium price relative to drugstore vitamin C toners
  • ✗ Methylparaben preservation deters paraben-averse users
  • ✗ Added fragrance limits suitability for fragrance-averse users
  • ✗ Brightening contribution still modest compared with leave-on high-concentration serums
  • ✗ Limited US availability typically requires import
Review

Full Review

Vitamin C is far more chemically diverse than the marketing on the front of any bottle would lead you to believe. The pure form, L-ascorbic acid, is biologically active the moment it touches skin but notoriously temperamental — it oxidizes readily, degrading the product across its shelf life and sometimes turning it an unappetizing brown. To get around that fragility, cosmetic chemists have spent years building derivative forms that trade a little immediacy for a lot of stability: ascorbyl glucoside, magnesium ascorbyl phosphate, ascorbyl tetraisopalmitate, ethyl ascorbic acid, and APPS among them, each with its own penetration and conversion profile. Dr. Ci:Labo's VC100 Essence Lotion EX is interesting precisely because it doesn't pick one derivative and call it a day — it pairs two of the more sophisticated options, APPS and 3-O-ethyl ascorbic acid, for layered vitamin C action in a toner format.

APPS, trisodium ascorbyl palmitate phosphate, is the formula's most compelling feature and the ingredient that anchors the entire VC100 line. Its defining trait is that it is amphiphilic — it carries both water-soluble and lipid-soluble character, which gives it a penetration advantage over purely water-soluble derivatives that struggle to cross the skin's lipid barrier. Once it gets in, it converts to active L-ascorbic acid and delivers the standard vitamin C repertoire: tyrosinase inhibition for melanin reduction, support for collagen synthesis, and antioxidant defense. That penetration edge matters in a toner, where contact time is brief and the depth an active can reach in a short window genuinely affects the outcome. The evidence behind APPS reads as promising, well-researched within cosmetic chemistry circles though stopping short of the deep clinical bedrock of the most-studied actives.

The ethyl ascorbic acid plays a complementary role, a stable lipid-soluble derivative that is well-tolerated by sensitive skin and contributes a more sustained, gradual conversion to active vitamin C over time. Stacking the two is mechanistically more complete than the single-derivative toners that dominate this category. Around them sits an unusually elaborate hydration system: a quad hyaluronic acid complex pulling together four molecular forms — a high-molecular-weight sodium hyaluronate for surface hydration, low-molecular-weight hydrolyzed fragments for intermediate depth, and a lipophilic acetyl-modified form for a different penetration profile. Layering four HA forms in a toner is genuinely more than most formulations bother with. Niacinamide rounds it out with well-established barrier support and melanin-transfer inhibition, reinforcing the brightening direction; the old anxiety about niacinamide flushing in combination products has been put to rest by research, so its pairing with the vitamin C actives is synergistic rather than problematic.

Using it is the familiar toner ritual with a few distinguishing notes. The texture is a clear, lightly viscous liquid with real body from the HA content, settling to a soft satin finish, and skin reads as notably hydrated and lightly luminous afterward. The vitamin C contribution is gentle by design — Dr. Ci:Labo's philosophy favors sustained derivative action over the aggressive jolt of high-concentration L-ascorbic acid. The realistic arc is hydration and a subtle surface brightness in the first few weeks, building toward meaningful improvement in mild hyperpigmentation across eight to twelve weeks, and that depends heavily on rigorous SPF and ideally the broader VC100 routine carrying the load alongside it.

The trade-offs are worth naming squarely. At seventy-five dollars for 150ml of an imported toner, this is premium pricing that pulls the value score down, and the brightening contribution — while real — stays modest next to a leave-on high-concentration serum that lingers on the skin all night. The formula also includes added fragrance and methylparaben, which rules it out for anyone who is fragrance-averse or specifically avoiding parabens, and the limited US availability typically means tracking down a Japanese import. For an established, dermatologist-founded Tokyo cosmeceutical brand with a flagship vitamin C line, the active deck is genuinely thoughtful and the brand credibility is real, but none of that erases the price-of-entry friction.

It helps to understand where a vitamin C toner sits in a routine, because that context shapes whether the price makes sense. A toner is an early, thin layer applied after cleansing and before serums — its job is to prep and lightly treat, not to carry the full corrective load of a routine. Judged by that role, the Essence Lotion EX is doing more than most toners attempt, layering brightening derivatives and elaborate hydration into a step many products treat as a simple hydrating splash. But it also means anyone expecting it to single-handedly fade stubborn pigmentation is asking a toner to do a serum's job; the realistic outcome is incremental support that compounds when the rest of the routine, including a dedicated treatment step and disciplined sun protection, pulls in the same direction. Within the brand's own VC100 system — the matching emulsion and cream — the toner reads as the opening move in a coordinated brightening sequence rather than a solo act, which is the most flattering and most accurate way to use it. With twelve thousand reviews behind it and several years on market, the data confidence here is genuinely high, so the gentle brightening claim is well-supported rather than speculative.

The right buyer here is specific: someone deliberately seeking Japanese cosmeceutical vitamin C depth, who values derivative-based, sustained brightening over L-ascorbic acid intensity, and who wants the hydration layering and dermatologist-developed pedigree that justify the premium for the target demographic. Anyone chasing dramatic, fast pigmentation correction on a budget, or anyone who needs fragrance-free and paraben-free, should look elsewhere without guilt. As a thoughtfully engineered toner that does real if gentle work, it is one of the more substantive options in the premium imported category — you just have to want what it specifically offers.

Formula

Key Ingredients

The hero actives that drive this product's performance.

IngredientFunctionEvidence
APPS (Trisodium Ascorbyl Palmitate Phosphate) The amphiphilic vitamin C derivative that defines Dr. Ci:Labo's VC100 positioning. APPS combines water-soluble and lipid-soluble properties, enabling better skin penetration than pure L-ascorbic acid or simpler vitamin C derivatives. Documented effects include collagen synthesis support, melanin reduction, and antioxidant action. APPS is among the most-researched advanced vitamin C derivatives in cosmetic chemistry. Limited for Hyperpigmentation
3-O-Ethyl Ascorbic Acid (Ethyl Vitamin C) A stable, lipid-soluble vitamin C derivative that complements APPS's water-soluble action. Ethyl ascorbic acid is well-tolerated by sensitive skin and provides sustained-release antioxidant and brightening action. The dual vitamin C approach (APPS + ethyl ascorbic acid) is more sophisticated than single-form vitamin C toners. Limited for Hyperpigmentation
Quad Hyaluronic Acid Complex Four forms of hyaluronic acid working complementarily — hydrolyzed sodium hyaluronate (low molecular weight), hydrolyzed hyaluronic acid (low molecular weight peptide fragments), acetyl hyaluronic acid (lipophilic modified), and sodium hyaluronate (high molecular weight). The layered approach provides hydration at multiple skin depths and is notably elaborate for a toner formulation. Plausible mechanism for Dullness
Niacinamide Vitamin B3 contributing barrier function support, melanin transfer inhibition, and complementary brightening to the dual vitamin C actives. Niacinamide pairs synergistically with vitamin C in modern formulations — research has dispelled older concerns about niacin flushing from combination products. In this toner, niacinamide reinforces the brightening positioning. Emerging for Hyperpigmentation
Full INCI List · pH 5.5

Water, Glycerin, DPG, 1,2-Hexanediol, PEG-32, Ascorbyl Phosphate (APPS - Trisodium Ascorbyl Palmitate Phosphate), 3-O-Ethyl Ascorbic Acid, Hydrolyzed Sodium Hyaluronate, Hydrolyzed Hyaluronic Acid, Acetyl Hyaluronic Acid, Sodium Hyaluronate, Niacinamide, Hydrolyzed Collagen, Citric Acid, Sodium Citrate, EDTA-2Na, Phenoxyethanol, Methylparaben, Fragrance

Safety & Formulation Facts
✓ Pregnancy Safe ✗ Fragrance Free✓ Alcohol Free✓ Oil Free✓ Silicone Free✗ Paraben Free✓ Sulfate Free✗ Cruelty Free✗ Vegan✓ Fungal Acne Safe
Potential Irritants
FragranceMethylparaben
Common Allergens
Fragrance
Compatibility

Skin Match

Best For
Works For
Routine Step

toner

Time of Day

AM & PM

Layering Tips

Apply after cleansing as the toner step. Dispense onto cotton pad or palms; pat into skin. Pairs synergistically with the Dr. Ci:Labo VC100 series (Emulsion EX, cream) for complete brightening routine. Follow with treatment serum and moisturizer. The dual vitamin C content makes this a meaningful daily brightening contribution.

Results Timeline

Immediate: skin feels notably hydrated with the quad hyaluronic acid deck delivering substantial surface moisture. Short-term (2-4 weeks): subtle improvement in skin clarity and dullness. Full benefits (8-12 weeks): meaningful improvement in mild hyperpigmentation, particularly when paired with the broader VC100 routine and consistent SPF use.

Pairs Well With
Dr. Ci:Labo VC100 Emulsion EX (designed pair)Dr. Ci:Labo VC100 creamniacinamide serums for layered brighteningsunscreen SPF 50 in morning routine
Planning a combo? Check it against what you already use
Conflicts With
additional high-concentration vitamin C serums (potential redundancy)
See where it fits — layering order & night-splitting
Sample AM Routine
  1. Cleanser
  2. Dr. Ci:Labo VC100 Essence Lotion EX
  3. VC100 Emulsion EX
  4. Moisturizer
  5. Sunscreen SPF 50
Sample PM Routine
  1. Cleansing oil + foaming cleanser
  2. Dr. Ci:Labo VC100 Essence Lotion EX
  3. Treatment serum
  4. VC100 Emulsion EX or other moisturizer
Evidence

Science & Expert Perspective

The Science

APPS (Trisodium Ascorbyl Palmitate Phosphate) research documents the amphiphilic vitamin C derivative's skin penetration advantage versus purely water-soluble or lipid-soluble alternatives. Studies in cosmetic chemistry literature demonstrate APPS's conversion to active L-ascorbic acid in skin with documented tyrosinase inhibition and collagen synthesis support. Ethyl ascorbic acid research backs the stable lipid-soluble derivative's sustained-release vitamin C action. The combination provides layered vitamin C mechanism that single-derivative formulations cannot match. Quad hyaluronic acid research documents the benefits of different molecular weight forms working at different skin depths — high molecular weight provides surface hydration, low molecular weight provides intermediate depth action, and modified forms like acetyl hyaluronic acid provide unique penetration profiles. Niacinamide has substantial dermatological research backing its effects on barrier function, melanin transfer inhibition, and complementary brightening. The dermatologist-developed brand positioning adds credibility to the formulation engineering choices.

Dermatologist Perspective

Dermatologists generally view advanced vitamin C derivative formulations like Dr. Ci:Labo VC100 favorably for patients seeking gentler brightening alternatives to high-concentration L-ascorbic acid serums. The dual-derivative approach with sophisticated hyaluronic acid hydration deck is mechanistically sound. Concerns: the added fragrance and methylparaben for sensitive or paraben-averse patients; the modest brightening contribution requiring complementary leave-on actives for meaningful hyperpigmentation improvement. For appropriate patients, dermatological consensus is positive.

Guidance

Usage & Recommendations

How to Use

Apply after cleansing as the toner step. Dispense 3-5 drops onto cotton pad or palms; pat into skin. Use morning and evening. Pair with the broader VC100 routine (Emulsion EX, cream) for complete brightening effect. Always use SPF in morning routines to protect the vitamin C-treated skin from UV damage.

Value Assessment

At seventy-five dollars for the 150 ml bottle, this sits in the premium Japanese cosmeceutical toner range. Per-use cost approximately 75 cents to $1.20. Compared with luxury Western vitamin C products (Skinceuticals C E Ferulic at $182), VC100 Essence Lotion EX offers excellent value for the formulation sophistication. Compared with drugstore Japanese vitamin C alternatives, the premium reflects the advanced derivatives, dermatologist-developed positioning, and quad hyaluronic acid complex. For users specifically seeking sophisticated derivative-based vitamin C toner formulations, the price is reasonable.

Who Should Buy

Users seeking sophisticated derivative-based vitamin C toner formulations with dermatologist-developed brand credibility. J-beauty enthusiasts curious about Japanese cosmeceutical brightening approaches. Those building complete Dr. Ci:Labo VC100 routines. Mild-to-moderate hyperpigmentation users seeking gentle daily brightening contribution.

Who Should Skip

Users primarily concerned with cost-per-use may prefer drugstore vitamin C alternatives. Those seeking aggressive high-concentration L-ascorbic acid effects should choose serums like Skinceuticals C E Ferulic. Paraben-averse and fragrance-averse users should look for cleaner alternatives. Severely sensitive skin should patch test before regular use.

Ready to try Dr. Ci:Labo VC100 Essence Lotion EX?

Buy at Amazon ♥
Details

Product Details

Texture

A clear, lightly viscous liquid with the consistency of a thin essence. Absorbs to a soft satin finish.

Scent

A subtle fresh-citrus fragrance reflecting the vitamin C positioning.

Packaging

150 ml clear plastic bottle with the Dr. Ci:Labo medical-aesthetic visual language reflecting the cosmeceutical brand positioning.

Finish
satindewylightweight
What to Expect on First Use

First-time users notice the substantial hydration from the quad hyaluronic acid complex and the subtle vitamin C scent. The dermatologist-developed positioning is reflected in the formulation sophistication.

How Long It Lasts

About 2-3 months per unit applied morning and evening

Period After Opening

6 months

Opened yours? Track the toss-by date
Best Season

All Year

Background

The Story Behind This Product

Dr. Ci:Labo was founded in Tokyo in 1999 by Dr. Shuichiro Yoshinaga, a Japanese dermatologist who wanted to bridge clinical dermatology and consumer skincare. The VC100 line launched in the late 2000s and has become one of the brand's signature product ranges. The Essence Lotion EX represents the brand's premium vitamin C toner positioning, with progressive reformulations adding more sophisticated vitamin C derivatives and complementary actives over the line's market presence.

About Dr. Ci:Labo Established Brand (5–20 years)

Dr. Ci:Labo was founded in Tokyo in 1999 by dermatologist Dr. Shuichiro Yoshinaga as a cosmeceutical brand bridging clinical dermatology and consumer skincare. The brand is one of Japan's most recognizable dermatologist-developed lines, with the VC100 series as its flagship vitamin C product range. The VC100 Essence Lotion EX represents the brand's premium vitamin C toner positioning.

Brand founded: 1999 · Product launched: 2018
Myth vs. Reality

Common Myths

Myth

All vitamin C in skincare is the same.

Reality

Vitamin C exists in multiple forms with different stability, penetration, and efficacy profiles. Pure L-ascorbic acid is the most biologically active but also the most unstable. Derivatives like APPS, ethyl ascorbic acid, ascorbyl glucoside, and ascorbyl tetraisopalmitate offer better stability and skin tolerance but different rates of conversion to active L-ascorbic acid. APPS specifically combines water and lipid solubility for improved skin penetration.

FAQ

Frequently Asked Questions

What is APPS and how does it work?

APPS (Trisodium Ascorbyl Palmitate Phosphate) is an amphiphilic vitamin C derivative that combines water-soluble and lipid-soluble properties. The dual nature enables better skin penetration than pure L-ascorbic acid or simpler derivatives. APPS converts to active L-ascorbic acid in skin, providing collagen synthesis support, melanin reduction, and antioxidant action. It is among the most-researched advanced vitamin C derivatives in cosmetic chemistry.

Should I use this with other vitamin C products?

Use caution to avoid redundancy. The VC100 Essence Lotion EX already provides meaningful vitamin C content from APPS plus ethyl ascorbic acid. Adding a high-concentration L-ascorbic acid serum can be useful for users seeking aggressive brightening, but may be overkill for moderate concerns. Test for tolerance and adjust based on skin response.

Can I use it during pregnancy?

Yes — the formulation contains no salicylic acid, retinoids, or hydroquinone. APPS, ethyl ascorbic acid, hyaluronic acid forms, and niacinamide are all considered safe during pregnancy. The methylparaben preservation is well-vetted but a flag for users avoiding parabens during pregnancy on principle.

How does it compare with Skinceuticals C E Ferulic?

Skinceuticals C E Ferulic uses 15% L-ascorbic acid as its primary form — more biologically active but less stable and more irritation-prone than the derivatives in Dr. Ci:Labo VC100. The Japanese approach favors stable derivatives at moderate concentrations; the Western pharmaceutical approach favors pure L-ascorbic acid at high concentrations. Both work; the choice depends on tolerance and preference.

Reviews

What Reviewers Tend to Say

Recurring themes our editors read across retailer reviews of this product — summaries in our words, not quotations, and not a substitute for your own patch test.

Common Praise

Dual vitamin C approach more sophisticated than single-form competitors

Quad hyaluronic acid deck delivers substantial hydration

Visible brightening contribution with consistent use

Pairs synergistically with the broader VC100 line

Dermatologist-developed credibility

Common Complaints

Premium price for an imported toner

Methylparaben preservation deters paraben-averse users

Fragrance limits suitability for fragrance-averse users

Brightening contribution still modest compared with leave-on serums

Limited US availability typically requires Japanese import

Notable Endorsements
Dr. Ci:Labo dermatologist-developed positioning@cosme brightening category recognition
Related Conditions
dullnesshyperpigmentationdark spotsaging
Related Ingredients
vitamin chyaluronic acidniacinamide